Home7780 • TPE
add
Daiken Biomedical Co Ltd
Previous close
$181.50
Day range
$173.00 - $180.50
Year range
$173.00 - $240.00
Market cap
14.13B TWD
Avg Volume
1.02M
P/E ratio
42.41
Dividend yield
4.97%
Primary exchange
TPE
Market news
Financials
Income Statement
Revenue
Net income
| (TWD) | Jun 2025info | Y/Y change |
|---|---|---|
Revenue | 454.88M | 60.46% |
Operating expense | 248.83M | 71.35% |
Net income | 38.80M | 12.57% |
Net profit margin | 8.53 | -29.85% |
Earnings per share | — | — |
EBITDA | 46.34M | -1.56% |
Effective tax rate | 18.47% | — |
Balance Sheet
Total assets
Total liabilities
| (TWD) | Jun 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 1.19B | -3.25% |
Total assets | 1.69B | -7.76% |
Total liabilities | 577.63M | 0.10% |
Total equity | 1.11B | — |
Shares outstanding | 60.00M | — |
Price to book | 9.83 | — |
Return on assets | 6.67% | — |
Return on capital | 9.60% | — |
Cash Flow
Net change in cash
| (TWD) | Jun 2025info | Y/Y change |
|---|---|---|
Net income | 38.80M | 12.57% |
Cash from operations | 62.57M | 196.43% |
Cash from investing | -4.20M | 92.99% |
Cash from financing | -43.82M | -104.22% |
Net change in cash | -2.73M | -100.30% |
Free cash flow | 138.21M | — |
About
Daiken Bio, officially known as Daiken Biomedical Co., Ltd., is a Taiwanese health supplement company established in June 2018. The company focuses on the research, development, production, and sales of nutritional products formulated with clinically tested ingredients. Wikipedia
Founded
Jun 20, 2018
Employees
20
